Biocon Case Study – Marketing – Essay – Shipra10
Search
Essays
Sign up
Sign in
Contact us
Tweet
Index
/Business
Biocon Case Study – Marketing
Problem identification
Should BIOMAb be launched with phase 2 results or wait for phase 3 results?
Or should Biocon invest in phase 2 trials for other indications?
Developing the product strategy, pricing options, channel and the major means of communication
Situation analysis
Company:-
Incorporated in 1978 as a JV between Biocon Chemicals, Ireland and Dr. Mazumdar-Shaw, an Indian entrepreneur
Started as enzyme manufacturing company and later entered biopharmaceutical market by production of statins (FDA Approved).
Subsidiaries – Clingine, Syngene International
Expertise in fermentation process, leveraging its technology to enter biopharmaceuticals
Developed proprietary drug for head and neck cancer accidentally and becoming the first Indian company to explore this oppurtunity
Formed a JV with CIMAB to market BIOMAb in India
Now planning to enter property drug market; Obtained IPO in 2004;
New Product – BIOMAb
In phase 2 trials results were 100% for chemo and radiotherapy in combination with BIOMAb.
A chance to build new research and marketing capabilities.
Lack of experience in marketing and selling oncology drugs.
Competitor-
Erbitux a treatment manufactured by Imclone system in US
Distributed by Merck KGaA of Germany.
Introduced in India in April 2006 for colorectal cancer.
Merck expected formal approval from DCGI in late 2006 to use Erbitux for head and neck cancer.
Had phase 3 approval.
Biocon had advantage against Erbitux as it had 100% phase 2 results, it didn’t caused skin rashes and it could leverage its Indian origin
Customer-
Indian incidence of cancer rates for head and neck cancer were highest
Propensity of lower income worker to chew tobacco and smoke cigarettes
The health care system in India was majorly private
efficient and costly.
Nearly all of the patients paid out-of-pocket.
Biocon expected patients would be self-paying and given the high price of cancer drugs wouldn’t be able to afford it.
Context-
Regulatory environment –
Change in India patent law. Can retain the first mover advantage in India.
Economic Environment –
9% growth of economy in addition with awareness and education market was expected to increase.
Technological Environment –
Technological company was developing.
Collaborators-
CFA, Wholesaler, Retail/ Hospital Pharmacy and Doctors.
Problem – Analysis of Pros and Cons
Market attractiveness: The sector for head and neck cancer is largely untapped until now which will provide a first mover advantage. 21% of cases and 27% of deaths worldwide from head and neck cancer occurred in India. Also, the Indian economy is increasing at 9% annually, so market size is expected to go up. Also, the annual population growth rate of 1.4% could increase the market potential in future.

Cost Effectiveness: Fixed dosage of BIOMAb ( six doses) in contrast to Erbitux’s indefinite treatment plan will prove to be cost effective and provide a clearer picture of the cost involved to the patient at the time of prescription of the drug. And since 95% of the patients using this drug are estimated to be self-paying, hence this cost effectiveness will be a major advantage of BIOMAb.

Pricing:
Continue for 3 more pages »
Read full document
Download as (for upgraded members)
Citation Generator
MLA 7
CHICAGO
(2015, 10). Biocon Case Study – Marketing. EssaysForStudent.com. Retrieved 10, 2015, from
“Biocon Case Study – Marketing” EssaysForStudent.com. 10 2015. 2015. 10 2015 < "Biocon Case Study - Marketing." EssaysForStudent.com. EssaysForStudent.com, 10 2015. Web. 10 2015. < "Biocon Case Study - Marketing." EssaysForStudent.com. 10, 2015. Accessed 10, 2015. Essay Preview By: Shipra10 Submitted: October 19, 2015 Essay Length: 762 Words / 4 Pages Paper type: Essay Views: 577 Report this essay Tweet Related Essays Wachovia Case Study - Marketable Securities Wachovia Corporation ĐČЂ“ Marketable Securities A i. Trading securities are securities that are bought and held principally for the purpose of selling them in the 700 Words  |  3 Pages Nextcard - a Marketing Case Study Company Overview NextCard was an internet-based provider of consumer credit founded in 1996 with a mission to revolutionize the credit card industry with its online 570 Words  |  3 Pages Li Ning Marketing Case Study In its mission statement, Li-Ning vision is to be Ў§a world's leading brand in the sports goods industry.ЎЁ While it is obvious that Li-Ning has 567 Words  |  3 Pages Hp Case Study - Marketing Strategy Class Feb 22, 2007 Executive Summary Hewlett-Packard (HP) is one of the largest technology companies in the world. Founded in 1939, HP employs nearly 88,000 worldwide, 1,846 Words  |  8 Pages Similar Topics Marketing Malt Liquor Case Study Marketing Strategy Case Study Brand Get Access to 89,000+ Essays and Term Papers Join 209,000+ Other Students High Quality Essays and Documents Sign up © 2008–2020 EssaysForStudent.comFree Essays, Book Reports, Term Papers and Research Papers Essays Sign up Sign in Contact us Site Map Privacy Policy Terms of Service Facebook Twitter

Get Your Essay

Cite this page

Biocon Case Study And Cost Effectiveness. (July 8, 2021). Retrieved from https://www.freeessays.education/biocon-case-study-and-cost-effectiveness-essay/